|1.||Karumanchi, S Ananth: 9 articles (05/2012 - 06/2005)|
|2.||Larsson, A: 3 articles (01/2004 - 11/2001)|
|3.||Jauniaux, Eric: 2 articles (01/2014 - 01/2008)|
|4.||Muttukrishna, Shanthi: 2 articles (01/2014 - 01/2008)|
|5.||Cerdeira, Ana Sofia: 2 articles (01/2012 - 01/2010)|
|6.||Lim, Kee-Hak: 2 articles (01/2012 - 11/2005)|
|7.||Grammas, Paula: 2 articles (08/2011 - 09/2006)|
|8.||Folkman, Judah: 2 articles (02/2010 - 07/2005)|
|9.||Bosco, Maria Carla: 2 articles (07/2008 - 06/2002)|
|10.||Varesio, Luigi: 2 articles (07/2008 - 06/2002)|
08/01/2015 - "The angiogenic responses induced by release of angiogenic proteins from tumor cell-activated platelets are regulated by distinct molecular pathways."
01/01/2015 - "Anti-angiogenic peptides are therefore promising candidates in the treatment of cancer. "
01/01/2015 - "Increasing evidence suggests that levels of angiogenic proteins within blood platelets change at the earliest stages of cancer development and may thus provide a promising diagnostic and prognostic tool. "
06/01/2014 - "Last, tumor cells may regulate the selective secretion of angiogenic proteins from platelet granules, which enables the tumor to stimulate and stabilize the immature neovasculature in the tumor environment. "
03/01/2014 - "In view of recent findings that MMP-9 is pro-angiogenic, our results indicated that the combination of MMP inhibitors and anti-angiogenic peptides may generate novel molecules with potent in vivo anti-tumor effects."
04/01/2015 - "Placenta-derived angiogenic proteins and their contribution to the pathogenesis of preeclampsia."
05/01/2012 - "Measurement of circulating angiogenic proteins for the diagnosis and prediction of preeclampsia is still at an early stage but is rapidly evolving. "
03/01/2010 - "Change in amniotic fluid levels of multiple anti-angiogenic proteins before development of preeclampsia and intrauterine growth restriction."
01/01/2010 - "Abnormalities in these circulating angiogenic proteins are not only present during clinical preeclampsia, but also antedate clinical symptoms by at least 5-6 weeks. "
01/01/2010 - "Angiogenic proteins as aid in the diagnosis and prediction of preeclampsia."
07/01/2008 - "The authors investigated human carotid plaques to determine whether these hypoxia-inducible angiogenic proteins play a major role in intraplaque angiogenesis and hemorrhage. "
12/01/2011 - "Our data confirms previous studies showing that hASCs: 1) secrete pro-angiogenic proteins, which are upregulated following culture in hypoxia, and 2) migrate up gradients of PDGF-BB in vitro, while showing for the first time that a rat mesenteric model of angiogenesis induced by 48/80 increases the propensity of both hASCs and hBMSCs to assume perivascular phenotypes following injection. "
05/26/2015 - "In addition, kidneys of fKSC treated rats had an up-regulation of angiogenic proteins hypoxia-inducible factor-1α, VEGF and eNOS on day 3 (P < 0.05). "
08/15/2011 - "Despite considerable data in human tissues regarding vascular expression of hypoxia-related angiogenic proteins, there is little information regarding these proteins in the brain vasculature of transgenic AD mice. "
01/01/2008 - "Tissue hypoxia results in rapid angiogenesis in vivo, triggered by angiogenic proteins, including vascular endothelial growth factor (VEGF). "
|4.||Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
08/01/2004 - "Soluble selectins, sICAM, sVCAM, and angiogenic proteins in different activity groups of patients with inflammatory bowel disease."
04/01/2014 - "The aim of the study was to compare the concentrations of angiogenic proteins in patients with inflammatory bowel disease (IBD) and healthy controls and to analyze changes in the levels during infliximab and adalimumab treatment. "
07/01/2010 - "This study is the first to demonstrate diabetes-specific changes in vitreous lipid autacoids including arachidonate and docosahexanoate-derived metabolites indicating an increase in inflammatory versus anti-inflammatory lipid mediators that correlated with increased levels of inflammatory and angiogenic proteins, further supporting the notion that inflammation plays a role the pathogenesis of this disease."
01/01/2014 - "The angiogenic proteins angiopoietin (Ang)-1, Ang-2 and vascular endothelial growth factor (VEGF) are regulators of endothelial inflammation and integrity. "
|1.||Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
|4.||Proteins (Proteins, Gene)
|5.||Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
|6.||Matrix Metalloproteinase 2 (Gelatinase A)
|7.||Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
|8.||Interleukin-6 (Interleukin 6)
|10.||Antihypertensive Agents (Antihypertensives)
|3.||Heterologous Transplantation (Xenotransplantation)
|5.||Photochemotherapy (Photodynamic Therapy)